>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
糖基化终产物对人血管平滑肌细胞表达及分泌甲状旁腺激素相关肽和血管钙化的影响
作者:张琴1  刘乃丰2 
单位:1. 东南大学 医学院, 江苏 南京 210009;
2. 东南大学附属中大医院 心血管内科, 江苏 南京 210009
关键词:糖基化终末产物 人血管平滑肌细胞 细胞钙化 甲状旁腺激素相关肽 
分类号:R587.1;R543.5;R-33
出版年·卷·期(页码):2014·33·第五期(545-550)
摘要:

目的:观察糖基化终末产物(AGEs)对人血管平滑肌细胞表达及分泌甲状旁腺激素相关肽(PTHrP)功能的影响,探讨PTHrP影响血管平滑肌细胞钙化发生的相关机制。方法:不同浓度的AGE-BSA分别与人血管平滑肌细胞孵育相同时间后,检测各组细胞钙含量及碱性磷酸酶(ALP)活性判断钙化程度;酶联免疫吸附法检测各组细胞PTHrP的分泌量;实时荧光定量逆转录聚合酶链反应检测PTHrP、核心结合因子(cbfα1)及骨形态发生蛋白2(BMP-2)在各组细胞中的表达量。结果:随AGEs浓度增加,细胞中的钙含量及ALP活性增加(P<0.05),而细胞分泌的PTHrP量逐渐减少(P<0.05),且AGEs可促进cbfα1、BMP-2及PTHrP在血管平滑肌细胞的表达,这在较高浓度组较为显著(P<0.05)。结论:适当浓度的晚期AGEs可影响人血管平滑肌细胞PTHrP的表达水平及分泌量,促进钙含量增加,进而有助于血管钙化的发生。

Objective: To investigate the effects of advanced glycation end-products(AGEs) on expression and secretion of parathyroid hormone related peptide(PTHrP) in vitro cultured human vascular smooth muscle cells(HVSMCs), and explore the related mechanism of PTHrP influencing vascular smooth muscle cells calcification. Methods: HVSMCs were treated with AGE-BSA of indicated concentration or non-glycated BSA for same periods. The calcium contents and activity of alkaline phosphatase of cells were analyzed by microplate reader; PTHrP levels in the supernatant were detected by the enzyme-linked immunosorbent method. Real-time fluorescent quantitative reverse transcription polymerase chain reaction(RT-PCR) was performed to detect the expressive of PTHrP, core-binding factor α1(cbfα1) in human and bone morphogenetic protein-2(BMP-2) in vascular smooth muscle cells. Results: AGE-BSA increased calcium deposition and activity of alkaline phosphatase in HVSMCs in dose-independent manners(P<0.05), but reduced the secretion of PTHrP. Futhermore, the elevated AGE-BSA treatment on HVSMCs significantly enhanced the expression of cbfα1, BMP-2 and PTHrP, compared with the controls(P<0.05). Conclusion: The expression and secretion of PTHrP on human vascular smooth muscle cells can be effected by AGEs, and PTHrP may induce deposition of calcium on vascular smooth muscle cells, thereby contributing to the vascular calcification. However, the related mechanism will be further explored.

参考文献:

[1] MARTIN T J,MOSELEY J M,WILLIAMS E D.Parathyroid hormone-related protein:hormone and cytokine[J].J Endocrinol,1997,154:23-37.
[2] JUPPNER H,ABOU A B,FREEMAN M,et al.A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide[J].Science,1991,254:1024-1026.
[3] JONO S,NISHHIZAWA Y,SHIOI A,et al.Parathyroid Hormone-related peptide as a local regulator of vascular calcification:its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells[J].Arteriosclerosis,Thrombosis,and Vascular Biology,1997,17:1135-114.
[4] LIU F,FU P,FAN W X,et al.Involvement of parathyroid hormone-related protein in vascular calcification of chronic haemodialysis patients[J].Nephrology,2012,17(6):552-560.
[5] WON K B,CHANG H J,PRAK S H,et al.High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patients[J].Korean Circulation Journal,2012,42(5):335-340.
[6] 方丽娟,刘乃丰.二甲双胍对糖基化终末产物诱导血管平滑肌细胞钙化的抑制作用[J].东南大学学报:医学版,2011,30(2):269-273.
[7] RENNENBERG R J,KESSELS A G,SCHURGERS L J,et al.Vascular calcifications as a marker of increased cardiovascular risk[J].Vasc Health Risk Manage,2009,5:185-197.
[8] The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy[R].N Engl J Med,2000,42:381-389.
[9] 吴春彪,陆军,王宸.晚期糖基化终末产物在骨性关节炎中的研究进展[J].现代医学,2012,40(3):356-360.
[10] REN X,SHAO H,WEI Q,et al.Advanced glycation end-products enhance calcification in vascular smooth muscle cells[J].J Int Med Res,2009,37(3):847-854.
[11] YAMAGISHI S.Glycation[J].Nippon Rinsho,2010,68(5):809-813.
[12] TAKAHISA T,YOSUKE O,RENA T,et al.Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK[J].J Vasc Res,2009,46:572-580.
[13] TOSHIHIRO S,TATSUYA L,TAKEHISA S,et al.Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells[J].J Atheroscler Thromb,2011,18:670-683.
[14] 沈潇,刘乃丰.可溶性晚期糖基化终产物受体基础与临床研究新进展[J].东南大学学报:医学版,2013,32(3):364-369.
[15] WANG Z Q,JIANG Y C,LIU N F.Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes[J].Atherosclerosis,2012,221(2):387-396.
[16] XU B,CHIBBER R,RUGGIERO D,et al.Impairment of vascular endothelial progenitor cells by modifying nitric oxide synthase activity by advanced glycation end products[J].FASEB J,2003,56(6):1289-1291.
[17] AMANO K,HATA K,SUGITA A,et al.Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein[J].Molecular Biology of the Cell,2009,20:4541-4551.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414834 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364